Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.

Source:http://linkedlifedata.com/resource/pubmed/id/10052966

J. Med. Chem. 1999 Feb 25 42 4 593-600

Download in:

View as

General Info

PMID
10052966